Laura Nagy

The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada

Anne Roscher, Jaina Patel, Stacy Hewson et al. · Molecular Genetics and Metabolism · 2014 · 116 citations

Metabolic Syndrome, Metabolic Disorder, Diabetes +6

Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C.

Evangelia Tsiani, Elena Bogdanovic, Alexander Sorisky et al. · Diabetes · 1998 · 105 citations

Cellular Physiology, Insulin Signaling, Tyrosine Phosphatase Inhibitors +22

Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by ALDH7A1 genetic defect

Saadet Mercimek‐Mahmutoglu, Dawn Corderio, Laura Nagy et al. · Molecular Genetics and Metabolism Reports · 2014 · 27 citations · Full text

Evaluation of the quality of clinical data collection for a pan-Canadian cohort of children affected by inherited metabolic diseases: lessons learned from the Canadian Inherited Metabolic Diseases Research Network

Kylie Tingley, Monica Lamoureux, Michael Pugliese et al. · Orphanet Journal of Rare Diseases · 2020 · 18 citations · Full text

Use of waxy maize heat modified starch in the treatment of children between 2 and 5 years with glycogen storage disease type I: A retrospective study

Ghada Hijazi, Nisha Pai, Laura Nagy et al. · Molecular Genetics and Metabolism Reports · 2019 · 15 citations · Full text